www.fdanews.com/articles/150184-first-patient-enrolled-in-boston-scientific-reprise-ii-tavr-clinical-trial

First Patient Enrolled in Boston Scientific REPRISE II TAVR Clinical Trial

October 12, 2012

Boston Scientific has enrolled the first patient in the REPRISE II clinical trial to evaluate the safety and performance of the Lotus Valve System in up to 120 patients with severe aortic valve disease.
Benzinga